AgomAb Therapeutics N.V.

Contributing Author

Recent Articles by AgomAb Therapeutics N.V.

Feb-09	Agomab Announces Closing of Initial Public Offering AGMB +6.55% GlobeNewswire
Feb-05	Agomab Announces Pricing of Initial Public Offering AGMB GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information